Loading...
Market
Story
Biden Administration to Release Preliminary List of $2 Generic Drugs for Medicare Recipients, Saving Seniors $1.5 Billion Starting 2027
Oct 9, 2024, 10:06 AM
The Biden administration is set to release a preliminary list of generic drugs that will be available to Medicare recipients for no more than $2. This initiative is part of a broader effort to make lifesaving medications more affordable, particularly for seniors. The administration previously announced that it would allow Medicare to negotiate drug prices, which is expected to save seniors approximately $1.5 billion in the upcoming year. The list of $2 generic drugs is anticipated to be implemented starting in 2027, as reported by various sources including Axios and Reuters.
View original story
Similar markets
Cardiovascular • 25%
Diabetes • 25%
Mental Health • 25%
Other • 25%
Eliquis • 25%
Jardiance • 25%
Xarelto • 25%
Other • 25%
Eliquis • 25%
Jardiance • 25%
Xarelto • 25%
Other • 25%
Drug A • 25%
Drug B • 25%
Drug C • 25%
Other • 25%
Drug A • 25%
Drug B • 25%
Drug C • 25%
Other • 25%
Drug A • 25%
Drug B • 25%
Drug C • 25%
Other • 25%
Drug A • 25%
Drug B • 25%
Drug C • 25%
Other • 25%
Patients • 25%
Healthcare Providers • 25%
Pharmaceutical Companies • 25%
Part D Sponsors • 25%
Diabetes Medications • 25%
Cancer Medications • 25%
Osteoporosis Medications • 25%
Other Medications • 25%
Company A • 25%
Company B • 25%
Company C • 25%
Other • 25%
Mental health medications • 25%
Cardiovascular medications • 25%
Cancer medications • 25%
Other • 25%